Table 4. Change in LCA levels by Baseline Characteristics.
Characteristic | Minimal ΔLCA | Marked ΔLCA | ||
---|---|---|---|---|
0.002 [(−0.14)-0.07] μmol/L (n= 14) |
0.32 (0.13-1.28) μmol/L (n= 15) |
|||
Age, years | 42.4 (20.4-49.8) | 48.7 (30.7-75.5) | ||
p-value | 0.05 | |||
Female sex, n (%) | 4 (29) | 10 (67) | ||
p-value | 0.04 | |||
BMI | 27.4 (23.8-33.1) | 26.5 (20.6-38.8) | ||
p-value | 0.71 | |||
Colectomy, n (%) | 4 (29) | 3 (20) | ||
p-value | 0.58 | |||
Histologic stage≥2, n (%) | 11 (79) | 10 (67) | ||
p-value | 0.66 | |||
Alkaline phosphatase* | 3.5 (1.2-12.1) | 4.7 (1.41-12.5) | ||
p-value | 0.34 | |||
Aspartate aminotransferase* | 1.6 (0.8-3.8) | 2.2 (0.7-4) | ||
p-value | 0.94 | |||
Bilirubin, mg/dL* | 0.7 (0.3-2) | 0.8 (0.4-2) | ||
p-value | 0.74 | |||
Mayo risk score | −0.24 [(−0.67)-1.8] | 0.36 [(−1.05)-1.5] | ||
p-value | 0.31 |
Data are presented as the median (range) unless otherwise indicated. ΔLCA= lithocholic acid after treatment-lithocholic acid at entry BMI= Body Mass Index
Values represent multiples of the upper limits of normal.